If you liked this article you might like

Roche Lifts Full-Year Outlook After Solid Q2 Earnings Beat
China Was Right to Walk Away From Failed U.S. Trade Talks
Roche Expands Into App-Based Digital Health With mySugr Deal
Novartis Secures European Approval For Biosimilar Cancer Treatment Rixathon